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Abstract 
Neurodegenerative diseases such as Alzheimer's and Parkinson's are the main 
causes of age-related dementia. These diseases can be due to neuronal cell death 
and/or impairment of neurite outgrowth. Giant oyster mushroom (GOM), Pleurotus 
giganteus, is used as a nootropic to improve cognitive function. GOM can also be used 
to prevent the onset of dementia. The underlying mechanism behind the medicinal 
property of GOM is unclear. Previous studies have shown that GOM has a high 
concentration of uridine. In this study, I examined the effects of uridine on neurite 
outgrowth in the Neuro-2a (N2a) neuroblastoma cell line. We also examined the effects 
of various concentrations of uridine on neurite outgrowth in N2a cells. When exposed to 
uridine, N2a cells produced significantly longer neurite extensions (p<0.001) and 
exhibited a significant increase in neurite-bearing cells (p<0.001) with an ideal 
concentration of 100 µM. Our results suggest that uridine significantly promoted neurite 
outgrowth in N2a cells (p<0.001 ) . Future studies are required to identify the mechanism 
behind uridines therapeutic potential on neurodegenerative diseases. 
Background 
Neurodegenerative diseases have major social and economic burdens on the 
world's increasing population. The number of people living with dementia-related 
illnesses, such as Alzheimer's and Parkinson's disease, is continuing to increase at a 
rapid rate. A large portion of the geriatric population will experience some form of 
dementia-related illnesses, increasing the economic burden of heath care. With the 
central nervous system's (CNS) inability to repair itself after injury or progressive 
disease damage, there is currently no treatment for recovering human nerve function. 
The majority of therapeutic medicine found to prevent neurodegeneration are unable to 
cross the blood-brain barrier and reach the CNS [1,2). With the increasing need to 
prevent, or perhaps impede, the development and debilitating effects of 
neurodegenerative diseases, many people are turning to a more wholistic approach. 
One approach to this issue is to be aware of age-related diseases and to take 
action towards their prevention through dietary supplements and functional foods. An 
increasing amount of research has been focusing on functional foods and their bioactive 
constituents in our everyday diet [8]. Mushrooms have become known for their health 
benefits beyond providing nutrients. With an entire kingdom containing unique 
secondary metabolites, some can be used as an unlimited source of new 
pharmaceutical products [3]. Culinary-medicinal mushrooms have been used for their 
bioactive, secondary metabolites to reduce beta amyloid-induced neurotoxicity, neurite 
outgrowth stimulation, nerve growth factor synthesis, neuroprotective, antioxidant and 
anti-inflammatory effects [4]. Vitamin 0-enriched white button mushrooms (Agaricus 
bisporus) have been shown to improve the memory in mice for Alzheimer's diesease 
[5]. Mushrooms have even been found to produce compounds that promote neurite 
outgrowth. One example are erinacines and hericenones, isolated from the mushroom 
Hericium erinaceus, commonly called lions main, for their neuroprotective properties [6]. 
Since these brain-improving compounds can only be isolated from the mushrooms that 
produce them, an increasing amount of research is needed in order to identify the 
mechanism behind their medicinal properties. 
Pleurotus giganteus, commonly known as giant oyster mushroom (GOM), is used 
for culinary purposes. The consumption of this mushroom goes as far back as the 
indigenous people of Peninsular Malaysia [?]. Mushrooms of Pleurotus are commonly 
consumed all over the world for their flavor and high nutritional value [8]. Many in vitro 
studies of GOM have evaluated its anticancer, antioxidative, antifungal, 
hepatoprotective and neurite outgrowth capabilities [3-6,9-12]. GOM extracts exhibited 
neurite outgrowth in rat pheochromocytoma (PC12) and Neuro-2a (N2a) neuroblastoma 
cells [13, 14]. The main bioactive ingredient of GOM is believed to be uridine. 
Uridine is an RNA nucleotide and has been identified in multiple different 
mushroom species [15]. Specifically, it was recognized as one of the main bioactive 
compounds in the medicinal mushroom, Cordyceps militaris, containing 45.4 mg/kg 
extract of uridine [16]. Uridine is also present in breast milk [17] and, as a nucleotide, it 
is reported to have important physiological roles in breast feeding infants [18]. Uridine 
contributes to brain phosphatidylcholine synthesis via the Kennedy pathway [19, 20]. Its 
uptake into the brain and through the blood brain barrier (BBB) is initiated by specific 
nucleotide transporters. The rate at which uptake occurs is a major factor determining 
phosphatide synthesis. With uridine being a precursor of phosphatidylcholine, a 
membrane constituent, its presence in GOM may give us a better understanding of its 
medicinal properties. Previous studies have shown GOM extract increases neuronal 
outgrowth with uridine being the active ingredient [12]. 
In this study, we examined the effects of uridine on neurite outgrowth in Neuro-2a 
(N2a) neuroblastoma cell line. We found that treatment of N2a cultures with uridine 
significantly increased neurite extension, combined length of neurites per cell, as well as 
the percent of neurite-bearing cells. 
Methods 
Materials and cell culturing 
Mouse neuroblastoma cells (N2a) were obtained from American Type Culture Collection 
(Manassas, VA). The N2a cells were cultured in Dulbecco's Modified Eagle's Medium 
(DMEM), with L-glutamine, penicillin-streptomycin (Thermo-Fisher Scientific) and fetal bovine 
serum (FBS) (Atlanta Biologicals). Uridine (Sigma Chemicals) was dissolved in ethanol due to 
its poor solubility in water. Three different concentrations of uridine were studied: 50 µM, 100 
µM and 200 µM. All the cultures were maintained at 37 °C and 6.5% C02 in a humidified 
atmosphere. The cells were subcultured at 2-day intervals. 
Measurement of neurite outgrowth 
The N2a cells were plated in tissue culture plates at an initial concentration of 
50,000 cells per plate containing DMEM medium with 1 X L-glutamine, 1 X penicillin­
streptomycin, 10 mM of glucose, and 10% of FBS for 48 hours. To examine the effects 
of uridine on neurite outgrowth, the medium was carefully replaced with FBS-free 
medium and either 50 µM, 100 µM or 200 µM of uridine in ethanol along with an ethanol­
alone counterpart for each concentration. The cells were photographed using an 
Amscope MU 1400-CK digital camera attached to phase contrast microscope. Uridine's 
effect on neuronal growth was measured based on percent neurite-bearing cells, 
average neurite length and average combined length. The percentage of neurite­
bearing cells is the number of neurite-bearing cells divided by the total number of cells 
in a field, multiplied by 100. Neu rite outgrowths, defined as axon-like extensions, were 
quantified using lmageJ software by tracing the axon extension and recording their 
lengths. Neu rite length was measured in at least 100 cells per plate. Photos were taken 
from 12 different quadrants evenly distributed throughout the plate. Four photos in each 
quadrant plus two extra photos yields 50 photos per plate. Only axon extensions 
measuring 30 µm or more where counted for percent neurite-bearing cell. Average 
neurite length was calculated by measuring the longest axon extension per photo, but 
all measurements were used for combined neurite length. 
Statistical analysis 
This experiment consisted of three separate trials with different N2a cultures and 
reagents each time. All the experimental data were expressed as mean ± standard 
error. Statistical differences between groups were calculated by one-way analysis of 
variance (ANOVA). 
Results and discussion 
Uridine affects neurite outgrowth in N2a cells 
Uridine has been recognized as one of the main bioactive compounds in the 
medicinal mushroom Pleurotus giganteus (GOM). We examined uridine's effects to 
promote neuronal outgrowth in N2a cells. The N2a neuroblastoma cell line is derived 
from mouse C1300 tumor and differentiated into neuron-like cells [21]. The cells contain 
a type of neurofilament used as a structural axon protein. Other studies have shown 
that neurofilament proteins were expressed in N2a cells after treatment with GOM 
extract [13]. We used the N2a cell line as an in vitro model for this study To determine 
the optimum uridine concertation for neurite outgrowth activity, pure uridine, at the 
concentrations of 50 µM, 100 µM and 200 µM, was tested. The cells were incubated for 
48 hours in medium containing uridine dissolved in ethanol or ethanol alone (vehicle). 
The cells were then photographed and measurements were taken based on three 
different neural outgrowth parameters using lmageJ software. 
Incubation of N2a cells with ethanol alone had no effect on the percentage of 
neurite-bearing cells as compared to cell growth in medium alone (Fig 1 ). Treatment 
with uridine significantly (p<0.001) increased neurite outgrowth for all three 
concentrations (Figs 1 and 2). Concentrations of 50 µM induced 34.8% ± 13.1 % growth 
in neurite-bearing cells and 200 µM induced 36.1± 15% growth, both showed significant 
differences when compared to growth in the medium alone (p<0.001 ). Uridine at a 
concentration of 100 µM stimulated the highest (p<0.001) percentage of neurite-bearing 
cells 39.98±13.48%, almost double the amount seen in the ethanol control (Fig 3). The 
increase in uridine concentration from 100 µM to 200 µM did not cause additional 
neurite outgrowth stimulation. It actually caused a slight decrease in the percent of 
neurite-bearing cells. Previous studies have shown that GOM has a uridine 
concentration of 1.5 µM but can increase neural growth in a dose-dependent manner, 
up to 100 µM [12]. These findings support our results that 100 µM is the ideal 
concentration of uridine for optimal neural growth. Therefore, the optimum uridine 
concentration of 100 µM was used for the subsequent data analyses. 
The mean for the longest neurite extension of N2a cells as well as the longest 
neurite/axon extension per photo were also measured. Given that 50 photos were taken 
per plate and three trials were performed, a total of 150 neurons were measured for the 
effects of uridine, medium and ethanol alone. N2a cells treated with uridine significantly 
increased (p<0.001) neurite extension as compared to cells incubated with ethanol 
alone (Fig 4 ). In addition, the combined length of all axon extensions showed a 
significant difference (p<0.001) when treated with uridine (Fig 5). These results suggest 
uridine promotes neurite outgrowth in differentiating N2a cells with an optimum 
concentration of 100 µM. Former studies have shown the rate at which brain neurons 
form new dendritic spines depend upon three limiting compounds: uridine, DHA and 
choline. All three compounds are precursors of the phosphatides in neural membranes. 
Uridine supplements can increase brain phosphatide levels. Moreover, uridine can be 
an agonist for P2Y2 receptors stimulating the production of synaptic proteins [22]. 
Another study suggests that when uridine binds to P2Y receptors, it stimulates the 
MEK/ERK and Pl3K/AKt/mTOR pathways [12]. 
Conclusion 
The results from this study showed that treatment of N2a cells with uridine 
increased the percentage of neurite-bearing cells, neurite extension and combined 
length of neurites per cell. The optimum uridine concentration on neurite outgrowth was 
100 µM. Future in vivo studies should be performed in order to examine the beneficial 
effects of uridine in animal models to help elucidate its therapeutic potential in 
neurodegenerative diseases. 
Medium Ethanol Uridine 
Figure 1. Phase contrast photographs of N2a neurites incubated in medium alone, 
medium containing ethanol (vehicle) and 100 µM of uridine. 
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Figure 2. Incubation of N2a cells with uridine significantly (p<0.001) increased the 
percentage of neurite-bearing cells as compared to cells incubated with medium alone 
or ethanol. Three uridine concentrations (50 µM, 100 µM and 200 µM) are indicated in 
black. Uridine at a concentration of 100 µM stimulated the highest (p<0.001) percentage 
of neurite-bearing cells (39.98±13.48%) with almost double the amount of the ethanol 
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medium Ethanol Uridine 
Figure 3. Incubation of N2a cells with 100 µM of uridine significantly (p<0.001) 
increased the percent of neurite bearing cells as compared to cells incubated with 
medium and ethanol controls. Data are mean +/- standard error from 3 different trials. 
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Medium Ethanol Uridine 
Figure 4. Incubation of N2a cells with 100 µM of uridine significantly (p<0.001) 
increased neurite length as compared to cells incubated with medium and ethanol 























Uridne - Combined Length 
. ... ..... ... . ... ..... ........... .. .. . . . . .. . . ... .. ...... ...
111·:11111:1111 1111 1 
l.1:::11· 1::: : :::::::::::::::::::::::: 
� � � � � � � � � � � � � � � �� � �� � � � � ... :.:l :.:::.· : 
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Figure 5. Incubation of N2a cells with 100 µM of uridine significantly (p<0.001) 
increased combined length of neurite-bearing cells as compared to cells incubated with 
medium and ethanol controls. Data are mean +/- standard error from 3 different trials. 
Literature Cited 
1. Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013). 
GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & 
Therapeutics, 138(2 ), 155-175. https://doi.org/10.1016/Lpharmthera .2013.01.004 
2. Daneman, R., & Prat, A. (2015). The Blood-Brain Barrier. Cold Spring Harbor 
Perspectives in Biology, 7(1 ). httos://doi.orq/10.1101/cshperspect.a020412 
3. Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and 
immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60(3), 
258-27 4. https://doi.org/10.1007/s00253-002-1076-7 
4. Phan, C.-W., David, P., Naidu, M., Wong, K.-H., & Sabaratnam, V. (2015). 
Therapeutic potential of culinary-medicinal mushrooms for the management of 
neurodegenerative diseases: Diversity, metabolite, and mechanism. Critical Reviews in 
Biotechnology, 35(3), 355-368. https://doi.orq/10.3109/07388551.2014.887649 
5. Bennett, L., Kersaitis, C., Macaulay, S. L., Munch, G., Niedermayer, G., Nigro, J., 
Bird, M. (2013). Vitamin D2-Enriched Button Mushroom (Agaricus bisporus) Improves 
Memory in Both Wild Type and APPswe/PS1dE9 Transgenic Mice. PLOS ONE, 8(10), 
e 76362. https://doi .orq/10 .1371 /journal .pone .0076362 
6. Wong, K.-H., Naidu, M., David, R. P ., Bakar, R., & Sabaratnam, V. (2012). 
Neuroregenerative potential of lion's mane mushroom, Hericium erinaceus (Bull.: Fr.) 
Pers. (higher Basidiomycetes), in the treatment of peripheral nerve injury (review). 
International Journal of Medicinal Mushrooms, 14(5), 427-446. 
https://doi.ora/10.1615/intjmedmushr.v14.i5.1 O 
7. Lee, S. S., Chang, Y. S., & Noraswati, M. N. R. (2009). Utilization of macrofungi by 
some indigenous communities for food and medicine in Peninsular Malaysia. Forest 
Ecology and Management, 257(10), 2062-2065. 
https://doi.org/10.1016/j.foreco.2008.09.044 
8. Khan, M. A., & Tania, M. (2012). Nutritional and Medicinal Importance of Pleurotus 
Mushrooms: An Overview. Food Reviews International, 28(3), 313-329. 
https://doi.org/10.1080/87559129.2011.637267 
9. Phan, C.-W., Lee, G.-S., Macreadie, I. G., Malek, S. N. A., Pamela, D., & 
Sabaratnam, V. (2013). Lipid Constituents of the Edible Mushroom, Pleurotus giganteus 
Demonstrate Anti-Candida Activity. Natural Product Communications, 8(12), 
https://doi.org/10.1177/1934578X1300801228 
10. Karunarathna, S. C., Yang, Z. L., Raspe, 0., Ko Ko, T. W., Vellinga, E. C., Zhao, R.­
L., Hyde, K. D. (2012, January 5). Lentinus giganteus revisited: New collections from Sri 
Lanka and Thailand. https://doi.orq/info:doi/10.5248/118.57 
11. Baskaran, A., Chua, K. H., Sabaratnam, V., Ram, M. R., & Kuppusamy, U. R. 
(2017). Pleurotus giganteus (Berk. Karun & Hyde), the giant oyster mushroom inhibits 
NO production in LPS/ H202 stimulated RAW 264.7 cells via STAT 3 and COX-2 
pathways. BMC Complementary and Alternative Medicine, 17,40 
https://doi.orq/10.1186/s12906-016-1546-6 
12. Phan, C.-W., David, P., Wong, K.-H., Naidu, M., & Sabaratnam, V. (2015). Uridine 
from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying 
Mechanism. PLOS ONE, 10(11), e0143004. 
https://doi.org/10.1371/joumal.pone.0143004 
13. Phan, C.-W., David, P., Naidu, M., Wong, K.-H., & Sabaratnam, V. (2013). Neurite 
outgrowth stimulatory effects of culinary-medicinal mushrooms and their toxicity 
assessment using differentiating Neuro-2a and embryonic fibroblast BALB/3T3. BMC 
Complementary and Alternative Medicine, 13, 261. https://doi.org/10.1186/14 72-6882-
13-261 
14. Phan, C.-W., Wong, W.-L., David, P., Naidu, M., & Sabaratnam, V. (2012). 
Pleurotus giganteus (Berk.) Karunarathna & K.O. Hyde: Nutritional value and in vitro 
neurite outgrowth activity in rat pheochromocytoma cells. BMC Complementary and 
Alternative Medicine, 12(1), 1054. https://doi.org/10.1186/1472-6882-12-102 
15. Yang, F., Lv, R., Zhang, Y., & Xia, Z. (2012). Comparison study on nucleosides and 
nucleotides in edible mushroom species by capillary zone electrophoresis. Analytical 
Methods, 4(2), 546-549. https://doi.org/10.1039/C2A Y05793J 
16. Oas, S. K., Masuda, M., Sakurai, A., & Sakakibara, M. (2010). Medicinal uses of the 
mushroom Cordyceps militaris: Current state and prospects. Fitoterapia, 81(8). 961-
968. https://doi.org/10.1016/j.fitote.2010.07.010 
17. Thorell, L., Sjoberg, L. B., & Hernell, 0. (1996). Nucleotides in human milk: Sources 
and metabolism by the newborn infant. Pediatric Research, 40(6), 845-852. 
https://doi .org/10 .1203/00006450-199612000-00012 
18. Leach, J. L., Baxter, J. H., Molitor, B. E., Ramstack, M. B., & Masor, M. L. (1995). 
Total potentially available nucleosides of human milk by stage of lactation. The 
American Journal of Clinical Nutrition, 61(6), 1224-1230. 
https://doi.org/10.1093/ajcn/61.6.1224 
19. Cansev, M. (2006). Uridine and cytidine in the brain: Their transport and utilization. 
Brain Research Reviews, 52(2), 389-397. 
https://doi.org/10.1016/j.brainresrev.2006.05.001 
20. Pooler, A. M., Guez, D. H., Benedictus, R., & Wurtman, R. J. (2005). Uridine 
enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma 
cells. Neuroscience, 134(1 ), 207-214. 
https://doi.ora/10.1016/Lneuroscience.2005.03.050 
21. Radio, N. M., & Mundy, W.R. (2008). Developmental neurotoxicity testing in vitro: 
Models for assessing chemical effects on neurite outgrowth. NeuroToxico/ogy, 29(3), 
361-376. https://doi.orq/10.1016/Lneuro.2008.02.011 
22. Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. (2010). Nutritional modifiers of 
aging brain function: Use of uridine and other phosphatide precursors to increase 
formation of brain synapses. Nutrition Reviews, 68(suppl_2), S88-S101. 
https://doi.orq/10.1111/L1753-4887 .2010.00344.x 
